June 30, 2016
Oncology Care and CancerType ID
Classifying Cancer: Better Diagnosis, Better Prognosis.
One of the greatest medical challenges in oncology care is treating a cancer whose origin is unknown or uncertain after an initial diagnostic work-up.
In the oncology world, the most difficult cancers to diagnose are known as cancer of unknown primary (or CUP for short). Cancer patients diagnosed with CUP often have delays in treatment, suboptimal treatment options, and poor prognoses.
CancerTYPE ID is a validated molecular cancer classifier, developed by Biotheranostics, Inc. (San Diego, CA), to help oncologists and pathologists provide an accurate diagnosis for metastatic cancer patients with these unknown or uncertain cancer types.
Comments